Colgate-Palmolive (NYSE:CL) Receives $105.11 Average PT from Analysts

Shares of Colgate-Palmolive (NYSE:CLGet Free Report) have earned an average recommendation of “Moderate Buy” from the twenty-two brokerages that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have issued a buy rating on the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $105.11.

Several equities research analysts have recently weighed in on CL shares. JPMorgan Chase & Co. upped their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Stifel Nicolaus cut Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their price target for the company from $105.00 to $101.00 in a research report on Monday, October 28th. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Monday, December 16th. UBS Group upped their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Finally, TD Cowen cut their price target on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a report on Monday, October 28th.

Read Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Stock Performance

NYSE CL opened at $92.03 on Wednesday. Colgate-Palmolive has a twelve month low of $76.96 and a twelve month high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The stock has a market cap of $75.19 billion, a P/E ratio of 26.37, a PEG ratio of 3.31 and a beta of 0.43. The company’s 50-day simple moving average is $95.02 and its 200 day simple moving average is $98.65.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.17%. Colgate-Palmolive’s payout ratio is presently 57.31%.

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.34% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Colgate-Palmolive

Several institutional investors have recently modified their holdings of CL. State Street Corp grew its holdings in Colgate-Palmolive by 3.8% during the third quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after purchasing an additional 1,784,411 shares during the period. Geode Capital Management LLC boosted its position in shares of Colgate-Palmolive by 2.8% during the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company’s stock worth $2,095,325,000 after purchasing an additional 552,949 shares in the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of Colgate-Palmolive by 6.2% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock valued at $988,997,000 after buying an additional 557,492 shares during the period. Legal & General Group Plc increased its position in shares of Colgate-Palmolive by 0.8% in the 2nd quarter. Legal & General Group Plc now owns 7,785,101 shares of the company’s stock valued at $755,465,000 after buying an additional 61,413 shares in the last quarter. Finally, Barclays PLC raised its stake in Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after buying an additional 2,132,747 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

About Colgate-Palmolive

(Get Free Report

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.